semaglutide development history Safety and Pharmacokinetics of Single and Multiple Ascending Doses of the Novel Oral Human GLP-1 Analogue, Oral Semaglutide, in Healthy Subjects and Subjects with Type 2 Diabetes | Clinical Pharmacokinetics What's next for Ozempic after

More studies are ongoing to understand further the full extent of semaglutide's cardiovascular benefits and potential uses in other cardiovascular-risk populations

Semaglutide can be used as part of a comprehensive weight loss program

August 2021: Ozempic Associated With Heightened Risk of Diabetic Retinopathy Study results focused on diabetic retinopathy (DR) in patients taking semaglutide found that a higher risk for DR complications were observed with semaglutide in patients with proliferative and non-proliferative DR at baseline. However, researchers do acknowledge that worsening DR can be from rapid drops in blood glucose levels from diabetic medications

Patients with glutathione synthetase deficiency typically present in the neonatal period with hemolytic anemia, metabolic acidosis and neurological impairment

Trulicity is a GLP-1 receptor agonist licensed in the UK for type 2 diabetes mellitus treatment

Retrospective studies suggest a beneficial effect on CRC risk and recurrence in diabetes